Skip to main content
MindScape Retreat ibogaine treatment facility in Cozumel, Mexico
MindScape Retreat
The Complete Guide. Ibogaine Treatment in Mexico

Ibogaine Treatment in Mexico:
Safety, Process & Outcomes (2026)

A comprehensive, medically transparent guide to ibogaine therapy in Mexico. From legal status and cardiac screening to day-by-day treatment protocols and outcomes data from 900+ patients at MindScape Retreat, Cozumel.

Book Your Free Consultation

100% Confidential · No Obligation

900+
Patients Treated
Since 2019 across 40+ countries
0
Serious Complications
Zero adverse events on record
85%+
Withdrawal Elimination
Within 24 hours of treatment
$7,500
Core Program
7-day all-inclusive from Cozumel
DA
Medically reviewed by Dr. Arellano, M.D.
Clinical Director, MindScape Retreat · Board-certified physician specializing in ibogaine-assisted detoxification with over 900 patients treated.
Last reviewed: March 2026

Legal Status

Why Mexico Is the World's Leading Destination for Ibogaine Treatment

Ibogaine is classified as Schedule I in the United States, making it illegal to administer even in clinical research settings without special FDA authorization. In Mexico, ibogaine is not a scheduled substance and can be legally administered by licensed physicians in clinical environments.

This legal framework has made Mexico the global center for ibogaine therapy, attracting patients from the US, Canada, Europe, and beyond. MindScape Retreat operates on the island of Cozumel, Quintana Roo, under full Mexican medical law compliance with board-certified physicians directing every treatment.

Mexico's accessibility from the United States is a significant advantage. Direct flights to Cozumel International Airport (CZM) operate from Houston, Dallas, Miami, Charlotte, Atlanta, Chicago, and Denver, with flight times averaging 2 to 4 hours. MindScape provides complimentary airport transfers as part of every program.

MindScape Retreat exterior in Cozumel, Mexico

What Is Ibogaine?

Ibogaine is a naturally occurring psychoactive indole alkaloid derived from the root bark of Tabernanthe iboga, a West African shrub. It acts on multiple neurotransmitter systems simultaneously, including opioid, serotonin, dopamine, and NMDA receptors, producing a neuroplastic reset that interrupts addiction, alleviates depression, and facilitates trauma processing.

  • Resets opioid receptors, eliminating withdrawal within 12-24 hours
  • Upregulates GDNF and BDNF, promoting neural repair and new connections
  • Active metabolite noribogaine provides sustained effects for 24-48 hours
  • Multi-receptor mechanism addresses the neurological roots of addiction, not just symptoms

Medical Safety

Pre-Treatment Screening: The Foundation of Safe Ibogaine Therapy

Every patient at MindScape undergoes rigorous medical screening before treatment. This is non-negotiable and the single most important factor separating safe ibogaine clinics from dangerous ones. Our cardiac screening protocols meet or exceed published clinical safety guidelines.

Screening includes a 12-lead electrocardiogram (EKG) to evaluate the QTc interval. Ibogaine prolongs QTc, and patients with pre-existing prolongation or structural heart disease are not eligible. A complete blood panel assesses liver function, kidney function, and electrolyte balance. Every medication the patient takes is reviewed for potential interactions.

Psychological evaluation ensures the patient is prepared for the intensity of the ibogaine experience. Patients with active psychosis, uncontrolled bipolar disorder, or certain personality disorders may require alternative treatment approaches. This thorough screening is why MindScape has maintained zero serious complications across 900+ treatments.

Your Treatment Journey

Day-by-Day: What Happens During Ibogaine Treatment

01

Pre-Screening & Preparation (2 Weeks Before)

Remote medical screening begins with EKG, bloodwork, medication review, and psychological assessment. Two preparation sessions with a clinical psychologist set intentions, address fears, and establish a framework for the experience. Medication tapering protocols are initiated if needed for SSRIs, benzodiazepines, or opioids.

02

Arrival & Medical Assessment (Day 1-2)

Airport pickup and transfer to MindScape's Cozumel facility. On-site medical assessment confirms screening results. The attending physician reviews all findings with you, explains the treatment protocol in detail, and answers every question. Group orientation, room setup, nutritious meals, and guided relaxation prepare body and mind.

03

The Ibogaine Session (Day 3)

Ibogaine HCL is administered orally under direct physician supervision. Effects begin within 45-90 minutes. The acute visionary phase (4-8 hours) involves vivid introspective experiences. A physician and nurse remain at your bedside for the entire 18-36 hour session with continuous cardiac telemetry, pulse oximetry, and vital sign monitoring. IV hydration and comfort measures are available throughout.

04

TA Extract & 5-MeO-DMT (Day 4-5)

MindScape's unique protocol continues with Ibogaine Total Alkaloid (TA) extract, delivering all 12 natural iboga alkaloids for deeper neuroprotective and emotional healing effects. An optional 5-MeO-DMT session and NAD+ infusion amplify neuroplasticity and cellular restoration during the window of heightened brain flexibility.

05

Integration & Recovery (Day 5-7)

Daily therapy sessions process the experience with trained psychologists. Group integration circles, yoga, meditation, sound therapy, and ocean time support physical and emotional recovery. Sleep patterns normalize. Cognitive clarity returns. Patients report feeling profoundly different within days of treatment.

06

Post-Retreat Integration (90 Days)

The medicine opens the door; integration keeps it open. Up to 90 days of post-retreat support includes structured calls with your psychologist, integration coaching, community connection, and relapse prevention strategies. This sustained support is what transforms a single treatment into lasting change.

Treatment Investment

Ibogaine Treatment Cost in Mexico

5-Day Ibogaine Retreat

$6,500

Wellness, neuroplasticity, personal growth & introspective exploration. Full all-inclusive stay with ibogaine HCL session.

Core Program. 7 Day

$7,500

Addiction, PTSD, depression, anxiety, trauma. Full protocol: Ibogaine HCL + TA + 5-MeO-DMT + NAD+. All-inclusive.

Opioid / SSRI. 10-14 Day

$12,500

Extended medical supervision for opioid addiction or SSRI discontinuation. Supervised tapering protocol included.

Parkinson's. 14-18 Day

$14,500

GDNF neuroregeneration microdosing program. Daily physician monitoring. 62% average motor improvement documented.

All programs are fully all-inclusive: luxury accommodation, all meals, medical screening, ibogaine medication, 24/7 physician supervision, therapy sessions, wellness activities, and post-retreat integration support. No hidden fees. Payment plans available. Compare this to traditional US rehab at $30,000-$60,000 for 30 days with 40-60% relapse rates.

All-Inclusive Program

Everything Included in Your Treatment

Luxury accommodation with private room and en-suite bathroom
All nutritious meals designed for optimal healing
Comprehensive medical screening (EKG, bloodwork, liver panel)
Ibogaine HCL + Total Alkaloid (TA) full-spectrum protocol
Optional 5-MeO-DMT therapy session
NAD+ infusion therapy for cellular restoration
24/7 physician and nursing supervision throughout
Continuous cardiac monitoring during sessions
Daily individual therapy sessions with psychologist
Group integration therapy circles
Yoga, meditation, and mindfulness practices
Sound therapy with singing bowls
Cold water immersion therapy
Temescal (traditional Mayan sauna)
Therapeutic massage
Snorkel tour and ocean excursions
Airport pickup and transfer
Two pre-retreat preparation sessions
Up to 90 days post-retreat integration support
From $6,500

5-day wellness retreat starting price. 7-day core ibogaine program from $7,500. Specialized programs individually priced. Contact us for a personalized assessment.

Safety Data

Ibogaine Safety: Understanding and Mitigating the Risks

Ibogaine carries real medical risks that must be managed with rigorous clinical protocols. The primary concern is cardiac: ibogaine prolongs the QTc interval, which can trigger dangerous arrhythmias in susceptible individuals. This is precisely why comprehensive cardiac screening is mandatory before treatment.

Global ibogaine-related mortality data shows that virtually all fatalities have occurred in unmonitored settings, self-administration, or clinics without proper cardiac screening. When administered in a medically supervised environment with appropriate screening, continuous monitoring, and emergency protocols, ibogaine has an excellent safety profile.

MindScape Retreat has maintained zero serious complications across 900+ treatments since 2019. Our facility maintains emergency resuscitation equipment, advanced airway management, and cardiac medications on-site. The attending physician holds advanced cardiac life support certification. Cozumel General Hospital is 8 minutes from our location with a standing transfer agreement.

Medical monitoring during ibogaine treatment at MindScape Retreat

Clinical Outcomes

Treatment Outcomes: Data from 900+ Patients

MindScape Retreat maintains detailed outcome data across all patients treated since 2019. For opioid-dependent patients, over 85% report complete elimination of withdrawal symptoms within 24 hours of ibogaine administration. Follow-up at 30 and 90 days shows sustained reduction in cravings, improved mood stability, and measurable quality of life improvements. See our full outcomes page for condition-specific data.

For Parkinson's disease patients, our GDNF neuroregeneration protocol has documented an average 62% improvement in motor symptoms across 100+ patients, with improvements in tremor, rigidity, and gait persisting well beyond the treatment period.

Depression and PTSD patients report significant shifts in emotional processing, reduction of intrusive thoughts, and improved sleep within the first week post-treatment. The combination of ibogaine's neuroplastic reset with structured psychological integration produces outcomes that often exceed years of conventional therapy.

Choosing a Clinic

What to Look for in an Ibogaine Treatment Center

Physician-Led Protocol

A board-certified physician must direct the treatment and remain on-site throughout. Nurse-only supervision is insufficient for safe ibogaine administration.

Cardiac Screening

12-lead EKG is mandatory, not optional. Any clinic that does not require comprehensive cardiac evaluation before ibogaine is putting patients at unacceptable risk.

Continuous Monitoring

Cardiac telemetry, pulse oximetry, and vital signs must be monitored continuously for the entire 18-36 hour session. Spot-checks are not adequate.

Emergency Equipment

Defibrillator, advanced airway management, cardiac medications, and a hospital transfer plan must be in place. Ask any clinic about their emergency protocols.

Why MindScape

MindScape Retreat vs Other Mexican Ibogaine Clinics

 IbogaineTypical Ibogaine Clinic
ProtocolHCL + TA extract + 5-MeO-DMT + NAD+Single form (HCL or TA only)
Medical Staff24/7 physician + nursing at bedsideNurse or sitter on-call
Cardiac ScreeningEKG, bloodwork, liver panel mandatoryVaries, sometimes optional
Integration90-day post-retreat support includedLimited or no aftercare
AccommodationLuxury private rooms, all-inclusiveShared rooms, meals extra
Track Record900+ patients, zero complicationsOften undisclosed
Conditions12+ conditions with specialized protocolsPrimarily addiction

Explore condition-specific treatment guides: opioid addiction, fentanyl detoxification, depression, PTSD & TBI, methadone/Suboxone weaning, and Parkinson's disease. Compare ibogaine to alternatives: vs methadone, vs Suboxone, vs kratom, vs naltrexone.

Conditions We Treat

Specialized Ibogaine Protocols for Every Condition

Find Treatment Near You

Ibogaine Treatment for Patients by State

MindScape Retreat treats patients from every US state. Direct flights from most major cities. Browse all state pages.

FloridaTexasCaliforniaNew YorkIllinoisColoradoOhioVirginiaMassachusettsWashington

Frequently Asked Questions

Common Questions About Ibogaine Treatment in Mexico

Yes. Ibogaine is not a controlled substance in Mexico and can be legally administered in clinical settings under physician supervision. MindScape Retreat operates within full compliance of Mexican medical law on the island of Cozumel, Quintana Roo. While ibogaine is Schedule I in the United States, many Americans travel to Mexico specifically for legal, medically supervised ibogaine therapy.

At MindScape Retreat, programs range from $6,500 for a 5-day wellness retreat to $14,500 for specialized 14-18 day protocols. The core 7-day ibogaine program starts at $7,500 and is fully all-inclusive: accommodation, meals, medical screening, ibogaine medication, 24/7 physician supervision, therapy, and up to 90 days of post-retreat integration support. This is significantly less than the $30,000 to $60,000 cost of traditional 30-day US rehab programs.

All patients undergo a 12-lead EKG to evaluate cardiac QTc interval, complete blood panel including liver and kidney function, full medication review and interaction assessment, psychological evaluation, and detailed medical history review. Patients with prolonged QTc intervals, structural heart disease, or certain medication interactions are not eligible. This screening ensures the highest safety standards.

The ibogaine experience spans 18 to 36 hours from onset to resolution. The acute visionary phase lasts 4 to 8 hours, followed by an extended introspective processing phase. A physician and nurse provide continuous bedside monitoring throughout with cardiac telemetry, pulse oximetry, and regular vital sign checks.

Ibogaine has demonstrated efficacy for opioid addiction (fentanyl, heroin, prescription opioids), alcohol and cocaine dependency, methadone and Suboxone weaning, PTSD and complex trauma, treatment-resistant depression, SSRI discontinuation, Parkinson's disease motor symptoms, and traumatic brain injury. MindScape has treated 900+ patients across these conditions.

Cozumel offers legal ibogaine treatment, a tranquil Caribbean healing environment, direct flights from most major US cities (2-4 hours), proximity to Cozumel General Hospital (8 minutes), and treatment costs significantly lower than comparable clinical care elsewhere. The island's natural setting supports recovery without urban distractions.

Over 85% of opioid-dependent patients experience complete elimination of withdrawal symptoms within 24 hours. Follow-up data shows sustained improvement in cravings, mood, and quality of life at 30 and 90 days. Parkinson's patients see an average 62% improvement in motor symptoms. Individual outcomes vary based on condition, history, and integration engagement.

Yes. Cozumel International Airport (CZM) receives direct flights from Houston, Dallas, Miami, Charlotte, Atlanta, Chicago, Denver, and other US cities seasonally. Flight time averages 2 to 4 hours. MindScape arranges airport pickup and transfer as part of the all-inclusive program.

Start a Confidential Conversation

100% Confidential · No Obligation · Response Within 24 Hours

WhatsApp Us NowCall +1 786-761-7729

100% Confidential · No Obligation · Available 7 Days a Week

Begin Your Healing

Ready to explore ibogaine treatment in Mexico?

Contact us today for a free, no-obligation consultation. Our clinical team will answer every question, review your medical history, and determine if ibogaine therapy is right for you.

Book Your Free Consultation

100% Confidential · No Obligation

Evidence & Research

Explore the clinical evidence behind ibogaine therapy

Ibogaine Research HubNEW

150+ peer-reviewed studies, active clinical trials, and emerging evidence — curated by our medical team.

Clinical Trials 2026NEW

Every active ibogaine trial tracked: Stanford MISTIC, DemeRx FDA pathway, UTHealth $50M IMPACT, and more.

Safety Guide

Zero complications in 900+ treatments. Comprehensive cardiac screening and continuous monitoring protocols.

Success Rates

Clinical outcomes from 900+ patients: opioid addiction, PTSD, depression, and neurological conditions.